AndroGel Cost in Wisconsin 2026: Cash Prices, Insurance, Medicaid, and Compounded Alternatives

What Does AndroGel Actually Cost in Wisconsin Right Now?

The cash-pay price for a one-month supply of AndroGel in Wisconsin sits at approximately $510 in 2026, consistent with AbbVie's manufacturer list price. That figure applies to both the 1% and 1.62% formulations at most chain and independent Wisconsin retail pharmacies. The number has held relatively flat compared with 2024 and 2025 because no generic 1% testosterone gel has gained the same market traction as branded AndroGel in this state.

GoodRx and similar coupon tools can reduce that figure by 10 to 25 percent at participating Wisconsin pharmacies, though the exact amount depends on the specific pharmacy, the dosage strength, and whether the coupon overlaps with a current promotion. Walgreens, CVS, and Walmart locations across Milwaukee, Madison, Green Bay, and Appleton all participate in at least one major coupon program.

Testosterone gel is a Schedule III controlled substance under federal law. Wisconsin follows federal scheduling, so every fill requires a valid, current prescription from a licensed prescriber. The FDA-approved labeling for AndroGel specifies that therapy should begin only after two fasting morning serum testosterone measurements confirm a level below the laboratory reference range, typically below 300 ng/dL. [1]

The clinical rationale for treatment is well-supported. The Testosterone Trials (TTrials), a coordinated set of seven placebo-controlled studies in 790 men aged 65 and older with symptomatic hypogonadism, found that testosterone treatment improved sexual function, walking distance, bone density, and self-reported energy compared with placebo. [2] That data set is the most rigorous evidence base currently available for AndroGel-class products.

How Wisconsin Medicaid Handles AndroGel Coverage

Wisconsin Medicaid (ForwardHealth) covers AndroGel for male hypogonadism, but the program requires prior authorization before the first fill is paid. The PA criteria typically include documented low serum testosterone on two separate morning draws, a confirmed clinical diagnosis of hypogonadism, and attestation that the prescriber has ruled out secondary causes (pituitary or hypothalamic pathology). PA approvals generally run for 12 months and must be renewed annually.

For Medicaid members who meet those criteria, the out-of-pocket cost drops to the standard Wisconsin Medicaid copay structure, which is $3 or less per prescription fill for most recipients. Members enrolled in BadgerCare Plus follow the same prior authorization pathway.

Prescribers should submit PA requests through the ForwardHealth Online Portal. Turnaround time on testosterone-related PAs in Wisconsin is typically 3 to 5 business days for standard review. Urgent reviews, which require clinical documentation of acute symptomatic need, are processed within 24 hours under state rules.

The Endocrine Society Clinical Practice Guideline on male hypogonadism states that "testosterone therapy in men with age-related decline in testosterone who do not have classic hypogonadism is not recommended outside of a clinical trial." [3] Wisconsin Medicaid PA reviewers reference this guideline when evaluating whether a patient qualifies, so the clinical documentation submitted must distinguish classic hypogonadism from age-related testosterone decline.

Which Commercial Insurance Plans Cover AndroGel in Wisconsin?

Most commercial insurers operating in Wisconsin, including Anthem Blue Cross Blue Shield Wisconsin, Quartz, Dean Health Plan, Common Ground Healthcare Cooperative, and Molina Healthcare of Wisconsin, list testosterone gel products on formulary. The tier placement matters a great deal for cost.

AndroGel typically lands at Tier 3 (preferred brand) or Tier 4 (non-preferred brand) depending on the specific plan year formulary. Tier 3 copays for a 30-day supply range from $60 to $110 on most Wisconsin employer-sponsored plans. Tier 4 cost-sharing can reach $150 to $200 per fill before the deductible is met.

Step therapy is common. Several Wisconsin insurers require a patient to try and document an inadequate response or intolerance to a generic testosterone product (such as generic testosterone cypionate injection) before they approve AndroGel. If your plan includes a step-therapy requirement, ask your prescriber to document the specific clinical reason why gel is preferred over injection for you. Reasons that typically satisfy step-therapy exceptions include needle phobia with documented avoidance behavior, bleeding disorder precluding intramuscular injection, or patient-specific pharmacokinetic data showing suboptimal response to injectable testosterone.

A published analysis in JAMA examining testosterone prescribing trends noted that formulary barriers and step-therapy requirements significantly affect patient adherence to prescribed TRT regimens, with patients facing higher cost-sharing showing measurably lower 90-day refill rates. [4]

The AbbVie Savings Card: How It Works in Wisconsin

AbbVie runs a co-pay savings program called myAbbVie Assist. For commercially insured Wisconsin patients, the card can reduce the monthly out-of-pocket cost to as low as $0, subject to an annual cap (typically $3,000 to $4 to 000 in program savings per calendar year, though the terms are updated annually by AbbVie).

The card does not work for patients covered by any federal or state government program. That means Wisconsin Medicaid, BadgerCare Plus, Medicare Part D, and Tricare-covered patients are all excluded by program rules. Using the card while also holding government coverage is a federal anti-kickback violation; patients in that situation should not enroll.

To activate the card, a patient or prescriber visits myabbvie.com, enrolls online, and receives a savings card that functions as a secondary payer at the pharmacy register. The pharmacist applies it after the primary insurance adjudicates the claim. Most Wisconsin chain pharmacies have processed this card without issue.

For uninsured cash-pay patients, AbbVie also offers the myAbbVie Assist Patient Assistance Program. Eligibility is income-based, with a general household income threshold near 600 percent of the Federal Poverty Level (approximately $90,000 annually for a single-person household in 2026). Applications require a recent tax return or income documentation and a completed physician attestation form.

Compounded Testosterone Gel in Wisconsin: Legality, Cost, and Trade-Offs

Compounded testosterone gel is legal in Wisconsin when prepared by a licensed 503A compounding pharmacy. Section 503A of the federal Food, Drug, and Cosmetic Act permits a pharmacist to compound a drug product for an identified individual patient based on a valid prescription from a licensed practitioner. Wisconsin's Pharmacy Examining Board enforces state-level compounding standards that align with USP <795> (non-sterile compounding) guidelines.

The cost difference is the main reason patients consider compounded testosterone gel. A 503A-compounded testosterone gel (typically in concentrations of 1%, 1.62%, or 2%) runs approximately $120 per month at Wisconsin compounding pharmacies, compared with $510 for branded AndroGel. That is a savings of roughly $390 per month, or $4,680 per year, for a cash-pay patient.

The clinical trade-off involves standardization. FDA-approved AndroGel has undergone rigorous bioavailability and stability testing. Compounded formulations vary by pharmacy in their carrier base, absorption enhancers, and lot-to-lot testosterone concentration consistency. The FDA has not approved any compounded testosterone gel, and the agency's guidance notes that compounding should generally not serve as a substitute for a commercially available product without a documented clinical reason. [5]

Practical clinical reasons that support prescribing a compounded formulation include documented skin sensitivity or allergy to an excipient in the branded product, a required concentration not available commercially, or verified cost barrier with documented financial hardship. Prescribers in Wisconsin who write for compounded testosterone should document the specific rationale in the chart note.

The National Institutes of Health MedlinePlus testosterone topic page outlines the general pharmacology of topical testosterone and notes the importance of consistent daily application to the same anatomical site for stable serum levels. [6] Absorption varies by site: shoulders and upper arms produce more consistent serum levels than the abdomen in most patients.

Getting AndroGel Through Telehealth in Wisconsin

Telehealth prescribing of AndroGel is legal in Wisconsin. The Wisconsin Medical Examining Board permits controlled substance prescribing via synchronous audiovisual telemedicine when the prescriber holds a valid Wisconsin medical license, the patient is physically located in Wisconsin at the time of the encounter, and the prescriber conducts a complete evaluation that would satisfy in-person prescribing standards.

The Ryan Haight Online Pharmacy Consumer Protection Act of 2008 created a federal baseline requiring at least one in-person evaluation before a controlled substance could be prescribed via telemedicine. During the COVID-19 public health emergency, DEA temporary exceptions allowed prescribing without that initial in-person visit. As of 2025, the DEA's proposed special registration framework for telemedicine providers has not yet been finalized, and the current Wisconsin practice standard for initiating AndroGel via telehealth typically requires laboratory confirmation of low testosterone before or at the time of the first telehealth visit.

HealthRX providers operating in Wisconsin follow this pathway: the patient completes a baseline lab draw (two morning total testosterone, LH, FSH, hematocrit, PSA if age 40 or older) at a local LabCorp or Quest draw site, then attends a synchronous video visit for evaluation. If hypogonadism is confirmed and the patient meets criteria, a prescription is sent electronically to a Wisconsin pharmacy of the patient's choice.

The HealthRX Wisconsin Telehealth Testosterone Initiation Checklist covers six clinical gates: confirmed low testosterone on two draws, symptom inventory using a validated tool such as the ADAM questionnaire, PSA baseline for patients over 40, hematocrit below 50%, absence of active prostate cancer or breast cancer, and documented patient counseling on transference risk (the transfer of testosterone gel to female partners or children through skin contact). A prescriber who confirms all six gates can initiate therapy in a single telehealth encounter.

What's the Cheapest Way to Get Testosterone Gel in Wisconsin?

The lowest monthly cost pathway depends on insurance status.

For commercially insured patients: use the AbbVie myAbbVie Assist card alongside your insurance. If your plan covers AndroGel at Tier 3, the card may reduce your copay to $0 for the calendar year.

For Wisconsin Medicaid patients: submit a complete PA with two documented morning testosterone values and a clinical note specifying classic hypogonadism. Once approved, your copay is typically under $3.

For uninsured or underinsured cash-pay patients: a prescription for compounded testosterone gel from a licensed Wisconsin 503A pharmacy is likely your lowest-cost option at around $120 per month. Confirm the pharmacy's accreditation status through the Wisconsin Pharmacy Examining Board directory before filling.

For Medicare Part D patients: compare plan formularies at medicare.gov during Open Enrollment (October 15 through December 7 each year). Some Part D plans cover generic testosterone gel products at Tier 2, significantly below the cost of branded AndroGel.

A 2022 BMJ analysis of testosterone therapy cost-effectiveness found that treatment adherence drops sharply when monthly out-of-pocket cost exceeds $75 for patients earning below median household income, reinforcing the practical importance of matching patients to the lowest viable cost pathway rather than defaulting to the branded product. [7]

Monitoring Requirements and Ongoing Costs

Starting AndroGel is not a one-time expense. Wisconsin patients should budget for follow-up labs at 3 and 6 months after initiation, then annually once levels are stable. Standard monitoring includes total testosterone (draw 2 to 4 hours after gel application for peak approximation), hematocrit, and PSA for men over 40.

The Endocrine Society guideline recommends maintaining serum testosterone in the mid-normal range (400 to 700 ng/dL) and titrating dose accordingly. [3] AndroGel is available in 1.25 g and 2.5 g single-dose packets (1% formulation) and in a metered-dose pump (1.62% formulation delivering 20.25 mg per actuation). Starting dose is typically 50 mg/day (1% formulation), with re-evaluation at 6 to 8 weeks.

Lab costs in Wisconsin vary widely. Quest Diagnostics' self-pay total testosterone panel runs approximately $49 to $79 through their direct-to-consumer platform. LabCorp's equivalent panel is similarly priced. Patients with commercial insurance will typically have these covered under preventive or diagnostic lab benefits after deductible.

Hematocrit above 54% requires dose reduction or temporary discontinuation under both FDA labeling and Endocrine Society guidance. Patients with baseline hematocrit above 48% require more frequent monitoring, typically every 3 months for the first year of therapy. [1]

A documented rise in PSA of more than 1.4 ng/mL above baseline within 12 months, or any PSA above 4.0 ng/mL, should prompt urology referral before continuing testosterone therapy. Wisconsin urologists at major systems including UW Health, Froedtert, and Marshfield Clinic are experienced with testosterone-associated PSA surveillance.

Application Technique and Transference Prevention

Correct daily application is the single most modifiable variable affecting serum testosterone levels on gel therapy. Patients apply AndroGel once daily in the morning to clean, dry, intact skin on the shoulders, upper arms, or abdomen (formulation-dependent). The gel dries in approximately 5 minutes and should not be washed off for at least 2 hours.

Transference risk to female partners and children is real and documented. The FDA label for AndroGel carries a black-box warning for this reason. [1] Wisconsin patients should be counseled to wash hands after application, cover the application site with clothing, and avoid skin-to-skin contact at the application site until showering.

Serum testosterone levels on gel therapy show day-to-day variability of approximately 15 to 20% even with perfect adherence, which is greater than the variability seen with intramuscular testosterone cypionate injections. Patients who require very stable serum levels for symptom control may be better served by injectable testosterone, which is also available through HealthRX providers in Wisconsin at a significantly lower monthly cost (approximately $30 to $60 for generic testosterone cypionate).